Journals / Üroonkoloji Bülteni / 2017 / Cilt: 16 - Sayı: 1

Social Awareness on Early Diagnosis and Treatment of Bladder Cancer: Importance of Age and Education

Mesane Kanseri Erken Tanı ve Tedavisinde Toplumsal Farkındalık: Yaş ve Eğitim Düzeyinin Önemi

Pages
12–16
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The absence of significant difference between the groups based on education level points out the significance of further actions to be taken to raise social awareness in whole community for this matter

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We aimed to evaluate the recognition level of bladder cancer in the society by conducting a survey with regards to social awareness in early diagnosis of bladder cancer in this study.
📊
Key Findings & Data:Materials and Methods: The survey was conducted on 100 randomly selected patients who were admitted to our clinic in May 2016 for any complaints.
💡
Conclusion & Impact:The absence of significant difference between the groups based on education level points out the significance of further actions to be taken to raise social awareness in whole community for this matter
🔬Design:Survey & Empirical Study
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: We aimed to evaluate the recognition level of bladder cancer in the society by conducting a survey with regards to social awareness in early diagnosis of bladder cancer in this study. Materials and Methods: The survey was conducted on 100 randomly selected patients who were admitted to our clinic in May 2016 for any complaints. In the survey, the main focus was hematuria which is the first and the most common symptom of bladder cancer and questions and statements on this subject was used.Results: Of 100 patients, 67 (66.7%) were male, and 33 (33.3%) were female. Thirty six of the patients were younger than 50 (36%), and 64 of them (64%) were 50 years and older. Education level of 40 (40%) patients was found to be university level, and 60 (60%) patients we high school graduates or lower. Twenty seven (27%) patients had complains about blood in the urine, while 67 (67%) of them had no such complaint. Of 27 patients that had complaint about hematuria, which is the most important symptom of bladder cancer 22 (81%) were male and 5 (19%) were female. We divided the patients into two groups based on 50 age limit. Group 1 included patients who were below 50, while the group 2 consisted of patients who were 50 years old and above. The rates of immediate consultation were determined to be significantly higher in group 2 than group 1. The rate of consulting urology department in the presence of hematuria, and the rates of considering the risk of bladder cancer as a possible diagnosis were higher in group 2, but the difference was not statistically significant. There was no significant difference found between the two groups who were separated by age in terms of required diagnostic tests. The patients were divided into two more groups based on their education level. Group 3 included patients of university graduates, and group 4 included patients with high school graduates or lower. The rates of immediate consultation were significantly higher in group 4. In the event of hematuria, there was no significant difference between the two groups in terms of consulting urology department, considering the risk of bladder cancer as a possible diagnosis, or required diagnostic tests.Conclusion: We observed that a certain level of awareness has been formed in the society regarding hematuria on early diagnosis of the bladder cancer; however, there are still some problems managing this issue. The absence of significant difference between the groups based on education level points out the significance of further actions to be taken to raise social awareness in whole community for this matter

Özet

Amaç: Bu çalışmada mesane kanserinin erken tanısında toplumsal farkındalık açısından yapılan anketle toplumda mesane kanseri bilinirlik düzeyini değerlendirmeyi amaçladık. Gereç ve Yöntem: Kliniğimize Mayıs 2016'da herhangi bir şikayet ile başvurmuş rastgele seçilen 100 hastaya anket çalışması yapılmıştır. Ankette mesane tümörünün ilk ve en sık semptomu olan hematüri üzerinde durulmuş ve bu konuda sorular ve önermeler kullanılmıştır. Bulgular: Yüz hastanın 67'si (%66,7) erkek, 33'ü (%33,3) kadın hastaydı. Hastaların 36'sı (%36) 50 yaş altında, 64'ü (%64) 50 yaş ve üstüydü. Öğrenim düzeyi 40 (%40) hastada üniversite düzeyinde, 60 (%60) hastada lise ve altı olarak tespit edildi. Hastaların 27'sinde (%27) idrarda kanama şikayeti olmuş 67'sinde (%67) olmamıştı. Mesane kanserinin tanısında en önemli bulgu olan hematüri ile başvuran 27 hastanın 22'si (%81) erkek, 5'i (%19) kadındı. Hastaları 50 yaş sınırına göre 2 gruba ayırdık. Grup 1: 50 yaş altı, grup 2: 50 yaş ve üzeri olarak ayrıldı. Grup 2'deki hastaların grup 1'dekilere göre hemen başvuru oranı istatistiksel olarak anlamlı yüksek saptandı. Yine bu hastaların hematüri durumunda ürolojiye başvurma oranları ve tanıda mesane tümörü düşünme oranları daha yüksek saptandı; ama bu istatistiksel olarak anlamlı değildi. Yaşa bağlı ayrılan gruplarda istenmesi gereken tetkikler açısından anlamlı fark saptanmadı. Hastaları öğrenim düzeyine göre 2 gruba daha ayırdık. Grup 3 üniversite mezunu olarak, grup 4 lise mezunu ve altı olarak düzenlendi. Doktora hemen başvuru oranında grup 4'te istatistiksel olarak anlamlı yükseklik saptandı. Bu hastaların hematüri durumunda ürolojiye başvurma oranları, tanıda mesane tümörü düşünme oranları ve istenmesi gereken tetkikler açısından anlamlı fark saptanmadı. Sonuç: Mesane kanserinin erken tanısında hematüri konusunda toplumda belli bir bilincin oluştuğu; ancak bunu yönetmede birçok sorunun olduğunu gözlemledik. Öğrenim seviyesine göre anlamlı fark olmaması; bu konuda toplumun her kesimine bilinçlendirme yapılması gerekliliğini ortaya koymaktadır.

🔖

Cite This Article

DEĞER, D., ASLAN, Ö. D., ÇÖMEZ, K., EREN, F., ADIRBELLİ, S., ASLAN, G. (2017). Social Awareness on Early Diagnosis and Treatment of Bladder Cancer: Importance of Age and Education. Üroonkoloji Bülteni, Cilt: 16 - Sayı: 1, 12–16. https://ajindex.com/articles/334339

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Eser S, Yakut C, Özdemir R, et al. Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pac J Cancer Prev 2010;11:1731-1733
  2. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN2008, Cancer Incidence and MortalityWorldwide: IARC CancerBase No: 10. Lyon, France: International Agency for Research onCancer; http://globocan.iarc.fr, 2012
  3. Vikram R, Sandler CM, Ng CS. Imaging and staging of transitional cell carcinoma: Part 1, lower urinary tract. AJR Am J Roentgenol 2009;192:1481-1488
  4. National Cancer Institute, SurveillanceEpidemiology and End Results. http://seer.cancer.gov/, 2012
  5. Chou R, Dana T. Screening adults for bladder cancer: a review of the evidence for the U.S. preventive services task force. Ann Intern Med 2010;153:461-468
  6. Davis R, Jones JS, Barocas DA, et al. Diagnosis, evaluation and followup of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol 2012;188(6 Suppl):2473-2481
  7. Konety B, Lotan Y. Urothelial bladder cancer: biomarkers for detection and screening. BJU Int 2008;102:1234-1241
  8. Khadra, MH, Pickard, RS, Charlton, M, et al. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol 2000;163:524-527
  9. T.C.Sağlık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü. Küresel Yetişkin Tütün Araştırması Türkiye Raporu 2010. Sağlık Bakanlığı Yayın No: 2010;803:16
  10. Johnson DE, Hillis S. Carcinoma of the bladder in patients less than 40 years old. J Urol 1978;120:172-173
  11. Wan J, Grossman HB. Bladder carcinoma in patients age 40 years or younger. Cancer 1989;64:178-181
  12. Kutarski PW, Padwell A. Transitional cell carcinoma of the bladder in young adults. Br J Urol 1993;72:749-755
  13. Kurz KR, Pitts WR, Vaughan ED Jr. The natural history of patients less than 40 years old with bladder tumors. J Urol 1987;137:395-397
  14. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-543
  15. Millan Rodrìguez F, Toniolo GC, Bayarry JS, et al. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000;163:73-78
  16. Botteman MF, Pashos CL, Redaelli A, et al. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 2003;21:1315-1330
  17. Messing EM, Madeb R, Young T, et al. Long-term outcome ofhematuria home screening for bladder cancer in men. Cancer 2006;107:2173-2179
  18. Lotan Y, Svatek RS, Sagalowsky AI. Should we screen for